Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 · kind B2 · utility
1Cited by
67References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2013 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Aug 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods of treatment or prevention of ocular conditions caused by treatment with certain therapeutically active agents. The methods can include administering a cyclosporine, an analog or derivative thereof, or a combination thereof to an eye of a mammal suffering from an ocular condition cased by treatment with certain therapeutically active agents, which can include a chemotherapy agent or an antiviral agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.